Skip to main content
Equibles

JANUS HENDERSON GROUP PLC

Position in EXEL — Exelixis, Inc.

CIK 1274173 LONDON, X0
Back to EXEL Full portfolio

Position in EXEL

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$39,192,967
+$11,411,585 QoQ
Shares Held
913,802
+44.2% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 71% None 29%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,214,395,751 across 183 Biotechnology names. EXEL ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,541,732 $1,856,099,791
2 PRAX
Praxis Precision Medicines, Inc.
 3,458,863 $1,114,411,067
3 MDGL
Madrigal Pharmaceuticals, Inc.
 2,018,647 $1,056,701,142
4 BBIO
BridgeBio Pharma, Inc.
 13,179,013 $978,673,503
5 PCVX
Vaxcyte, Inc.
 16,575,875 $963,224,094
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,131,527 $951,812,064
7 RVMD
Revolution Medicines, Inc.
 9,766,496 $949,791,733
8 MIRM
Mirum Pharmaceuticals, Inc.
 6,945,813 $641,654,204

All Filings in EXEL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $39,192,967 913,802
2025-12-31 $27,781,382 633,844
2025-09-30 $12,968,199 314,000
2025-06-30 $22,024,747 499,654
2025-03-31 $6,844,044 185,375
2024-12-31 $4,159,335 124,905
2024-09-30 $3,200,853 123,347
2024-06-30 $2,744,620 122,146
2024-03-31 $3,259,481 137,357
2023-12-31 $3,298,576 137,498
2023-09-30 $3,010,645 137,787
2023-06-30 $2,633,912 137,829
2023-03-31 $2,678,326 137,987
2022-12-31 $3,391,544 211,443
2022-09-30 $13,150,078 838,653
2022-06-30 $22,463,072 1,078,918
2022-03-31 $36,286,257 1,600,629
2021-12-31 $36,571,004 2,000,602
2021-09-30 $38,838,112 1,837,186
2020-12-31 $17,541,802 874,031
2020-09-30 $107,826,798 4,410,094
2020-06-30 $125,918,930 5,304,083
2020-03-31 $62,234,647 3,614,091